pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2023-33-1-76-83pulmo-3507Research ArticleОБЗОРЫREVIEWЛечебно-диагностические и организационные аспекты хронической обструктивной болезни легких у женщинTreatment, diagnostics, and management of chronic obstructive pulmonary disease in womenhttps://orcid.org/0000-0001-7642-1256МалыхинФ. Т.MalykhinF. T.

Малыхин Федор Тимофеевич – кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней.

Малыхин Федор Тимофеевич – кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней.

355017, Ставрополь, ул. Мира, 310; тел.: (8652) 71-48-35

Fedor T. Malykhin -Candidate of Medicine, Associate Professor, Department of Propaedeutics of Internal Diseases.

Ul. Mira 310, Stavropol, 355017; tel.: (8652) 71-48-35

fmalykhin@yandex.ruhttps://orcid.org/0000-0002-6892-3552БатуринВ. А.BaturinV. A.

Батурин Владимир Александрович – доктор медицинских наук, профессор, заведующий кафедрой клинической фармакологии с курсом дополнительного профессионального образования.

355017, Ставрополь, ул. Мира, 310; тел.: (8652) 71-34-66

Vladimir A. Baturin - Doctor of Medicine, Professor, Head of the Department of Clinical Pharmacology with an Additional Professional Education Course.

Ul. Mira 310, Stavropol, 355017; tel.: (8652) 71-34-66

prof.baturin@gmail.comФедеральное государственное бюджетное образовательное учреждение высшего образования Ставропольский государственный медицинский университет, Министерство здравоохранения Российской ФедерацииРоссияFederal State Budgetary Educational Institution of Higher Education Stavropol State Medical University, Ministry of Health of the Russian FederationRussian Federation2023100220233317683Copyright © Малыхин Ф.Т., Батурин В.А., 20232023Малыхин Ф.Т., Батурин В.А.Malykhin F.T., Baturin V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/3507

Хроническая обструктивная болезнь легких (ХОБЛ) – существенное обременение состояния здоровья женщин. В научных исследованиях и на практике этой проблеме уделяется недостаточно внимания, хотя появляется все больше информации об отличиях лечебнодиагностических и организационных аспектов ХОБЛ в зависимости от пола пациентов.

Целью обзора явились оценка имеющихся на сегодня наиболее значимых данных по специфике клинической картины, течения и исхода ХОБЛ у женщин и выработка предложений по достижению наилучших результатов в диагностике и лечении этого заболевания.

Заключение. Существует обусловленная биологическими и культурными различиями разница клинических проявлений, течения и исхода ХОБЛ у представителей разных полов с вытекающими из этого соответствующими практическими последствиями. Установлена целесообразность применения индивидуализированных диагностических, организационных и фармакотерапевтических подходов у женщин с ХОБЛ, основанных на знании специфических для женского пола различий в симптомах заболевания и состоянии здоровья пациенток.

Chronic obstructive pulmonary disease (COPD) poses a significant burden on women’s health. Insufficient attention is paid to this problem in scientific research and in clinical practice, although more and more information surfaces about the gender-associated differences in the treatment, diagnostics, and management of COPD.

The aim of the review is to consider the most significant data currently available on the clinical signs, course, and outcomes of COPD in women and propose ways to achieve the best results in the diagnosis and treatment of this disease.

Conclusion. There are biological and cultural differences between the clinical manifestations, course and outcome of COPD in men and women, and these differences impact the clinical practice. It is advisable to apply individualized diagnostic, organizational, and pharmacotherapeutic approaches to COPD in women, based on the knowledge of female-specific variances in the symptoms of the disease and the health status.

хроническая обструктивная болезнь легкихлечебно-диагностические аспектыорганизационные проблемыженщиныполовые различияchronic obstructive pulmonary diseasetreatment and diagnostic aspectsorganizational problemswomengender differencesСпонсорская поддержка отсутствовалаThere was no funding for the articleReferencesСо А.К., Авдеев С.Н., Нуралиева Г.С. и др. Предикторы неблагоприятного исхода при обострении хронической обструктивной болезни легких. Пульмонология. 2018; 28 (4): 446–452. DOI: 10.18093/0869-0189-2018-28-4-446-452.So A.K., Avdeev S.N., Nuralieva G.S. et al. [Predictors poor outcomes in acute exacerbations of chronic obstructive pulmonary disease]. Pul’monologiya. 2018; 28 (4): 446–452. DOI: 10.18093/0869-0189-2018-28-4-446-452 (in Russian).Малыхин Ф.Т. Особенности этиологии, патогенеза и патологической морфологии хронической обструктивной болезни легких у женщин и мужчин. Пульмонология. 2021; 31 (4): 530–536. DOI: 10.18093/0869-0189-2021-31-4-530-536.Malykhin F.T. [Typical features of the etiology, pathogenesis and pathological morphology of chronic obstructive pulmonary disease in women and men]. Pul’monologiya. 2021; 31 (4): 530–536. DOI: 10.18093/0869-01892021-31-4-530-536 (in Russian).Кириллова Д.А., Татарский А.Р. Отечный синдром у пациентов с ХОБЛ: механизмы развития, подходы к лечению. Российский медицинский журнал. 2017; 23 (4): 191–196. DOI: 10.18821/08692106-2017-23-4-191-196.Kirillova D.A., Tatarsky A.R. [The edematous syndrome in patients with chronic obstructive pulmonary disease of lungs: mechanisms of development and approaches to treatment]. Rossiyskiy meditsinskiy zhurnal. 2017; 23 (4): 191–196. DOI: 10.18821/0869-2106-2017-23-4-191-196 (in Russian).Малыхин Ф.Т., Титоренко Е.В., Батурин В.А., Форсикова Н.Г. Метаболический синдром и присоединение бактериальной инфекции как факторы риска фатального исхода при гриппе А/H1N1, осложненном пневмонией. Пульмонология. 2012; (5): 105–109. DOI: 10.18093/0869-0189-2012-0-5-105-109.Malykhin F.T., Titorenko E.V., Baturin V.A., Forsikova N.G. [Metabolic syndrome and bacterial infection as risk factors of death in influenza А/H1N1 complicated by pneumonia]. Pul’monologiya. 2012; (5): 105–109. DOI: 10.18093/0869-0189-2012-0-5-105-109 (in Russian).Заболеваемость населения старше трудоспособного возраста (с 55 лет у женщин и с 60 лет у мужчин) по России в 2018 году с диагнозом, установленным впервые в жизни: статистические материалы. М.: ФГБУ «ЦНИИОИЗ» Минздрава Российской Федерации; 2019. Доступно на: http://www.demoscope.ru/weekly/2020/0843/biblio05.php [Дата обращения: 08.05.21].Morbidity of the population over the working age (from 55 years for women and from 60 years for men) in Russia in 2018 with a diagnosis established for the first time in life: Statistical materials]. Moscow: FGBU “CNIIOIZ” Minzdrava Rossiyskoy Federacii, 2019. Available at: http://www.demoscope.ru/weekly/2020/0843/biblio05.php [Accessed: May 08, 2021] (in Russian).Tsiligianni I., Rodríguez M.R., Lisspers K. et al. Call to action: improving primary care for women with COPD. NPJ Prim. Care Respir. Med. 2017; 27 (1): 11. DOI: 10.1038/s41533-017-0013-2.Tsiligianni I., Rodríguez M.R., Lisspers K. et al. Call to action: improving primary care for women with COPD. NPJ Prim. Care Respir. Med. 2017; 27 (1): 11. DOI: 10.1038/s41533-017-0013-2.van Boven J.F.M., Román-Rodríguez M., Palmer J.F. et al. Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life. Chest. 2016; 149 (4): 1011–1020. DOI: 10.1016/j.chest.2015.12.002.van Boven J.F.M., Román-Rodríguez M., Palmer J.F. et al. Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real life. Chest. 2016; 149 (4): 1011–1020. DOI: 10.1016/j.chest.2015.12.002.European Lung White Book. Chapter 13: Chronic obstructive pulmonary disease. Available at: https://www.erswhitebook.org/files/public/Chapters/13_COPD.pdfEuropean Lung White Book. Chapter 13: Chronic obstructive pulmonary disease. Available at: https://www.erswhitebook.org/files/public/Chapters/13_COPD.pdfNattori K., Kida K. Management of older adults with COPD. Nihon Rinsho. 2016; 74 (5): 858–863. Available at: https://www.researchgate.net/publication/311796891_Management_of_older_adults_with_COPD [Accessed: May 10, 2021].Nattori K., Kida K. Management of older adults with COPD. Nihon Rinsho. 2016; 74 (5): 858–863. Available at: https://www.researchgate.net/publication/311796891_Management_of_older_adults_with_COPD [Accessed: May 10, 2021].Fuller-Thomson E., Chisholm R.S., Brennenstuhl S. COPD in a population-based sample of never smokers: interactions among sex, gender, and race. Int. J. Chronic Dis. 2016; 2016: 5862026. DOI: 10.1155/2016/5862026.Fuller-Thomson E., Chisholm R.S., Brennenstuhl S. COPD in a population-based sample of never smokers: interactions among sex, gender, and race. Int. J. Chronic Dis. 2016; 2016: 5862026. DOI: 10.1155/2016/5862026.Vogelmeier C.F., Criner G.J., Martinez F.J. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2017; 195 (5): 557–582. DOI: 10.1164/rccm.201701-0218PP.Vogelmeier C.F., Criner G.J., Martinez F.J. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2017; 195 (5): 557–582. DOI: 10.1164/rccm.201701-0218PP.World Health Organization. Chronic obstructive pulmonary disease (COPD). Available at: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) [Accessed: January 15, 2020].World Health Organization. Chronic obstructive pulmonary disease (COPD). Available at: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd) [Accessed: January 15, 2020].Aryal S., Diaz-Guzman E., Mannino D.M. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 1145–1154. DOI: 10.2147/copd.s54476.Aryal S., Diaz-Guzman E., Mannino D.M. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 1145–1154. DOI: 10.2147/copd.s54476.Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2019 Report. Available at: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7FINAL-14Nov2018-WMS.pdf [Accessed: January 19, 2020].Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. 2019 Report. Available at: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7FINAL-14Nov2018-WMS.pdf [Accessed: January 19, 2020].Lopez-Campos J.L., Ruiz-Ramos M., Soriano J.B. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysis. Lancet Respir. Med. 2014; 2 (1): 54– 62. DOI: 10.1016/S2213-2600(13)70232-7.Lopez-Campos J.L., Ruiz-Ramos M., Soriano J.B. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysis. Lancet Respir. Med. 2014; 2 (1): 54– 62. DOI: 10.1016/S2213-2600(13)70232-7.World Health Organization. Chronic respiratory disease. Available at: https://www.who.int/health-topics/chronic-respiratory-diseases#tab=tab_1 [Accessed: May 08, 2021].World Health Organization. Chronic respiratory disease. Available at: https://www.who.int/health-topics/chronic-respiratory-diseases#tab=tab_1 [Accessed: May 08, 2021].Ancochea J., Miravitlles M., García-Río F. et al. Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch. Bronconeumol. 2013; 49 (6): 223–229. DOI: 10.1016/j.arbres.2012.11.010.Ancochea J., Miravitlles M., García-Río F. et al. Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions. Arch. Bronconeumol. 2013; 49 (6): 223–229. DOI: 10.1016/j.arbres.2012.11.010.Balgoma D., Yang M., Sjödin M. et al. Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD. Eur. Respir. J. 2016; 47 (6): 1645–1656. DOI: 10.1183/13993003.01080-2015.Balgoma D., Yang M., Sjödin M. et al. Linoleic acid-derived lipid mediators increase in a female-dominated subphenotype of COPD. Eur. Respir. J. 2016; 47 (6): 1645–1656. DOI: 10.1183/13993003.01080-2015.Пелевина И.Д., Шапорова Н.Л., Трофимов В.И. и др. Гендерные особенности курительного статуса, уровня никотиновой зависимости, респираторной симптоматики и мотивации к отказу от табакокурения. Ученые записки Санкт-Петербургского государственного медицинского университета имени академика И.П.Павлова. 2018; 25 (2): 39–45. DOI: 10.24884/1607-4181-2018-25-2-39-45.Pelevina I.D., Shaporova N.L., Trofimov V.I. et al. [Gender peculiarities of smoking status, level of the nicotine dependence, respiratory symptoms and motivation to tobacco cessation]. Uchenye zapiski Sankt-Peterburgskogo gosudarstvennogo medicinskogo universiteta imeni akademika I.P.Pavlova. 2018; 25 (2): 39–45. DOI: 10.24884/1607-4181-2018-25-2-39-45 (in Russian).Кытикова О.Ю., Гвозденко Т.А., Антонюк М.В. Современные аспекты распространенности хронических бронхолегочных заболеваний. Бюллетень физиологии и патологии дыхания. 2017; (64): 94–100. DOI: 10.12737/article_5936346fdfc1f3.32482903.Kytikova O.Yu., Gvozdenko T.A., Antonyuk M.V. [Modern aspects of prevalence of chronic bronchopulmonary diseases]. Byulleten’ fiziologii i patologii dyhaniya. 2017; (64): 94–100. DOI: 10.12737/article_5936346fdfc1f3.32482903 (in Russian).Raherison C., Tillie-Leblond I., Prudhomme A. et al. Clinical characteristics and quality of life in women with COPD: an observational study. BMC Womens Health. 2014; 14 (1): 31. DOI: 10.1186/14726874-14-31.Raherison C., Tillie-Leblond I., Prudhomme A. et al. Clinical characteristics and quality of life in women with COPD: an observational study. BMC Womens Health. 2014; 14 (1): 31. DOI: 10.1186/14726874-14-31.Jain N.K., Thakkar M.S., Jain N. et al. Chronic obstructive pulmonary disease: does gender really matter? Lung India. 2011; 28 (4): 258–262. DOI: 10.4103/0970-2113.85686.Jain N.K., Thakkar M.S., Jain N. et al. Chronic obstructive pulmonary disease: does gender really matter? Lung India. 2011; 28 (4): 258–262. DOI: 10.4103/0970-2113.85686.Celli B., Vestbo J., Jenkins C.R. et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am. J. Respir. Crit. Care Med. 2011; 183 (3): 317–322. DOI: 10.1164/rccm.201004-0665OC.Celli B., Vestbo J., Jenkins C.R. et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am. J. Respir. Crit. Care Med. 2011; 183 (3): 317–322. DOI: 10.1164/rccm.201004-0665OC.Roche N., Deslee G., Caillaud D. et al. Impact of gender on COPD expression in a real-life cohort. Respir. Res. 2014; 15 (1): 20. DOI: 10.1186/1465-9921-15-20.Roche N., Deslee G., Caillaud D. et al. Impact of gender on COPD expression in a real-life cohort. Respir. Res. 2014; 15 (1): 20. DOI: 10.1186/1465-9921-15-20.Han M.K., Kazerooni E.A., Lynch D.A. et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011; 261 (1): 274–282. DOI: 10.1148/radiol.11110173.Han M.K., Kazerooni E.A., Lynch D.A. et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011; 261 (1): 274–282. DOI: 10.1148/radiol.11110173.Agusti A., Calverley P.M., Celli B. et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir. Res. 2010; 11 (1): 122. DOI: 10.1186/1465-9921-11-122.Agusti A., Calverley P.M., Celli B. et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir. Res. 2010; 11 (1): 122. DOI: 10.1186/1465-9921-11-122.Beeh K.M., Glaab T., Stowasser S. et al. Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial. Respir. Res. 2013; 14 (1): 116. DOI: 10.1186/1465-9921-14-116.Beeh K.M., Glaab T., Stowasser S. et al. Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial. Respir. Res. 2013; 14 (1): 116. DOI: 10.1186/1465-9921-14-116.Varol Y., Anar C., Çimen P. et al. Sex-related differences in COPD Assessment Test scores of COPD populationswith or without significant anxiety and/or depression. Turk. J. Med. Sci. 2017; 47 (1): 61–68. DOI: 10.3906/sag-1509-60.Varol Y., Anar C., Çimen P. et al. Sex-related differences in COPD Assessment Test scores of COPD populationswith or without significant anxiety and/or depression. Turk. J. Med. Sci. 2017; 47 (1): 61–68. DOI: 10.3906/sag-1509-60.Li Y., Dai Y.L., Yu N., Guo Y.M. Sex-related differences in bronchial parameters and pulmonary function test results in patients with chronic obstructive pulmonary disease based on three-dimensional quantitative computed tomography. J. Int. Med. Res. 2018; 46 (1): 135–142. DOI: 10.1177/0300060517721309.Li Y., Dai Y.L., Yu N., Guo Y.M. Sex-related differences in bronchial parameters and pulmonary function test results in patients with chronic obstructive pulmonary disease based on three-dimensional quantitative computed tomography. J. Int. Med. Res. 2018; 46 (1): 135–142. DOI: 10.1177/0300060517721309.Малыхин Ф.Т. Возрастные особенности бронхов и легких у людей пожилого и старческого возраста. Морфология. 2019; 155 (1): 66–72.Malykhin F.T. [Age-related characteristics of the bronchi and lungs in the elderly and senile people]. Morfologiya. 2019; 155 (1): 66–72 (in Russian).Calzetta L., Puxeddu T., Rogliani P. Gender-related responsiveness to the pharmacological treatment of COPD: a first step towards the personalized medicine. EBioMedicine. 2017; 19: 14–15. DOI: 10.1016/j.ebiom.2017.04.035.Calzetta L., Puxeddu T., Rogliani P. Gender-related responsiveness to the pharmacological treatment of COPD: a first step towards the personalized medicine. EBioMedicine. 2017; 19: 14–15. DOI: 10.1016/j.ebiom.2017.04.035.Naberan K., Azpeitia A., Cantoni J., Miravitlles M. Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir. Med. 2012; 106 (3): 367–373. DOI: 10.1016/j.rmed.2011.09.014.Naberan K., Azpeitia A., Cantoni J., Miravitlles M. Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir. Med. 2012; 106 (3): 367–373. DOI: 10.1016/j.rmed.2011.09.014.Овчаренко С.И. Сердечно-сосудистая патология у больных хронической обструктивной болезнью легких: как мы лечим? Русский медицинский журнал. 2018; 10 (I): 36–39. Доступно на: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Serdechno-sosudistaya_patologiya_ubolynyh_hronicheskoy_obstruktivnoy_boleznyyu_legkih_kak_my_lechim/#ixzz71cmjR2fH [Дата обращения: 25.07.21].Ovcharenko S.I. [Cardiovascular pathology in patients with chronic obstructive pulmonary disease: how do we treat it? Russkiy meditsinskiy zhurnal. 2018; 10 (I): 36–39. Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Serdechno-sosudistaya_patologiya_ubolynyh_hronicheskoy_obstruktivnoy_boleznyyu_legkih_kak_my_lechim/#ixzz71cmjR2fH [Accessed: July 25, 2021] (in Russian).Barrecheguren M., Roman-Rodriguez M., Miravitlles M. Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD? Int. J. Chron. Obstruct. Pulmon. Dis. 2015; 10: 1745–1752. DOI: 10.2147/COPD.S87025.Barrecheguren M., Roman-Rodriguez M., Miravitlles M. Is a previous diagnosis of asthma a reliable criterion for asthma-COPD overlap syndrome in a patient with COPD? Int. J. Chron. Obstruct. Pulmon. Dis. 2015; 10: 1745–1752. DOI: 10.2147/COPD.S87025.Tam A., Churg A., Wright J.L. et al. Sex differences in airway remodeling in a mouse model of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2016; 193 (8): 825–834. DOI: 10.1164/rccm.201503-0487OC.Tam A., Churg A., Wright J.L. et al. Sex differences in airway remodeling in a mouse model of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2016; 193 (8): 825–834. DOI: 10.1164/rccm.201503-0487OC.Assaggaf H., Felty Q. Gender, estrogen, and obliterative lesions in the lung. Int. J. Endocrinol. 2017; 2017: 8475701. DOI: 10.1155/2017/8475701.Assaggaf H., Felty Q. Gender, estrogen, and obliterative lesions in the lung. Int. J. Endocrinol. 2017; 2017: 8475701. DOI: 10.1155/2017/8475701.Кытикова О.Ю., Гвозденко Т.А., Кнышова В.В. Хроническая обструктивная болезнь легких у женщин. Бюллетень физиологии и патологии дыхания. 2019; (72): 103–111. https://doi.org/10.12737/article_5d0ad13e586137.59996983Kytikova O.Yu., Gvozdenko T.A., Knyshova V.V. [Chronic obstructive pulmonary disease in women]. Byulleten’ fiziologii i patologii dyhaniya. 2019; (72): 103–111. DOI: 10.12737/article_5d0ad13e586137.59996983 (in Russian).Hong Y., Ji W., An S. et al. Sex differences of COPD phenotypes in nonsmoking patients. Int. J. Chron. Obstruct. Pulmon. Dis. 2016; 11: 1657–1662. DOI: 10.2147/COPD.S108343.Hong Y., Ji W., An S. et al. Sex differences of COPD phenotypes in nonsmoking patients. Int. J. Chron. Obstruct. Pulmon. Dis. 2016; 11: 1657–1662. DOI: 10.2147/COPD.S108343.Montserrat-Capdevila J., Godoy P., Marsal J.R. et al. Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study. BMC Fam. Pract. 2015; 16: 173. DOI: 10.1186/s12875-015-0387-6.Montserrat-Capdevila J., Godoy P., Marsal J.R. et al. Risk of exacerbation in chronic obstructive pulmonary disease: a primary care retrospective cohort study. BMC Fam. Pract. 2015; 16: 173. DOI: 10.1186/s12875-015-0387-6.Rahmanian S.D., Diaz P.T., Wewers M.E. Tobacco use and cessation among women: research and treatment-related issues. J. Womens Health (Larchmt). 2011; 20 (3): 349–357. DOI: 10.1089/jwh.2010.2173.Rahmanian S.D., Diaz P.T., Wewers M.E. Tobacco use and cessation among women: research and treatment-related issues. J. Womens Health (Larchmt). 2011; 20 (3): 349–357. DOI: 10.1089/jwh.2010.2173.Ekstrom P., Jogreus C., Strom K.E. Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS One. 2012; 7 (4): e35806. DOI: 10.1371/journal.pone.0035806.Ekstrom P., Jogreus C., Strom K.E. Comorbidity and sex-related differences in mortality in oxygen-dependent chronic obstructive pulmonary disease. PLoS One. 2012; 7 (4): e35806. DOI: 10.1371/journal.pone.0035806.Ferrari R., Tanni S.E., Lucheta P.A. et al. Gender differences in predictors of health status in patients with COPD. J. Bras. Pneumol. 2010; 36 (1): 37–43. DOI: 10.1590/s1806-37132010000100008.Ferrari R., Tanni S.E., Lucheta P.A. et al. Gender differences in predictors of health status in patients with COPD. J. Bras. Pneumol. 2010; 36 (1): 37–43. DOI: 10.1590/s1806-37132010000100008.Martinez C.H., Raparla S., Plauschinat C.A. et al. Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J. Womens Health (Larchmt). 2012; 21 (12): 1267–1274. DOI: 10.1089/jwh.2012.3650.Martinez C.H., Raparla S., Plauschinat C.A. et al. Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J. Womens Health (Larchmt). 2012; 21 (12): 1267–1274. DOI: 10.1089/jwh.2012.3650.Авраменко Л.П., Болотнова Т.В. Особенности хронической обструктивной болезни легких у женщин. Тюменский медицинский журнал. 2013; 15 (2): 3–4. Доступно на: https://cyberleninka.ru/article/n/osobennosti-hronicheskoy-obstruktivnoy-bolezni-legkih-u-zhenschin/viewer [Дата обращения: 19.01.21].Avramenko L.P., Bolotnova T.V. [Features of chronic obstructive pulmonary disease in women]. Tyumenskij medicinskij zhurnal. 2013; 15 (2): 3–4. Available at: https://cyberleninka.ru/article/n/osobennosti-hronicheskoy-obstruktivnoy-bolezni-legkih-u-zhenschin/viewer [Accessed: January 19, 2021] (in Russian).Миронова Н.В., Нарышкина С.В. Тревожно-депрессивные расстройства у больных хронической обструктивной болезнью легких. Бюллетень физиологии и патологии дыхания. 2015; (55): 132–139. Доступно на: https://cfpd.elpub.ru/jour/article/view/688/618 [Дата обращения: 08.05.21].Mironova N.V., Naryshkina S.V. [Anxiodepressive disorders in patients with chronic obstructive pulmonary disease]. Byulleten’ fiziologii i patologii dyhaniya. 2015; (55): 132–139. Available at: https://cfpd.elpub.ru/jour/article/view/688/618 [Accessed: May 08, 2021] (in Russian).Yohannes A.M., Raue P.J., Kanellopoulos D. et al. Predictors of allcause mortality in patients with severe COPD and major depression admitted to a rehabilitation hospital. Chest. 2016; 149 (2): 467–473. DOI: 10.1378/chest.15-0529.Yohannes A.M., Raue P.J., Kanellopoulos D. et al. Predictors of allcause mortality in patients with severe COPD and major depression admitted to a rehabilitation hospital. Chest. 2016; 149 (2): 467–473. DOI: 10.1378/chest.15-0529.Айсанов З.Р., Калманова Е.Н. Новые принципы диагностики хронической обструктивной болезни легких. Фарматека. 2012; (15): 62–66. Доступно на: https://pharmateca.ru/ru/archive/article/8589 [Дата обращения: 08.05.21).Aisanov Z.R., Kalmanova E.N. [New principles of diagnosis of chronic obstructive pulmonary disease]. Farmateka. 2012; (15): 62–66. Available at: https://pharmateca.ru/ru/archive/article/8589 [Accessed: May 08, 2021] (in Russian).Okley J.A., Shaheen S., Weiss A., Gale C.R. Wellbeing and chronic lung disease incidence: the survey of health, ageing and retirement in Europe. PLoS One. 2017; 12 (7): e0181320. DOI: 10.1371/journal.pone.0181320.Okley J.A., Shaheen S., Weiss A., Gale C.R. Wellbeing and chronic lung disease incidence: the survey of health, ageing and retirement in Europe. PLoS One. 2017; 12 (7): e0181320. DOI: 10.1371/journal.pone.0181320.Gonzalez A.V., Suissa S., Ernst P. Gender differences in survival following hospitalisation for COPD. Thorax. 2011; 66 (1): 38–42. DOI: 10.1136/thx.2010.141978.Gonzalez A.V., Suissa S., Ernst P. Gender differences in survival following hospitalisation for COPD. Thorax. 2011; 66 (1): 38–42. DOI: 10.1136/thx.2010.141978.Chuchalin A.G., Khaltaev N., Antonov N.S. et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 963–974. DOI: 10.2147/COPD.S67283.Chuchalin A.G., Khaltaev N., Antonov N.S. et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int. J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 963–974. DOI: 10.2147/COPD.S67283.Nguyen L.P., Beck E., Cayetano K. et al. Differential pulmonary rehabilitation outcomes in patients with and without COPD: role of gender. J. Cardiopulm. Rehabil. Prev. 2017; 37 (5): 350–355. DOI: 10.1097/HCR.0000000000000275.Nguyen L.P., Beck E., Cayetano K. et al. Differential pulmonary rehabilitation outcomes in patients with and without COPD: role of gender. J. Cardiopulm. Rehabil. Prev. 2017; 37 (5): 350–355. DOI: 10.1097/HCR.0000000000000275.Козлов Е.В., Деревянных Е.В., Балашова Н.А., Яскевич Р.А. Медико-психологические аспекты и оценка комплаентности у больных хронической обструктивной болезнью легких мужского пола. Современные проблемы науки и образования. 2016; (6): 170. Доступно на: https://s.science-education.ru/pdf/2016/6/25768.pdf [Дата обращения: 25.07.21].Kozlov E.V., Derevyannyh E.V., Balashova N.A., Yaskevich R.A. [Medical and psychological aspects and assessment of compliance in male patients with chronic obstructive pulmonary disease]. Sovremennye problemy nauki i obrazovaniya. 2016; (6): 170. Available at: https://s.science-education.ru/pdf/2016/6/25768.pdf [Accessed: July 25, 2021] (in Russian).Vozoris N.T., Stanbrook M.B. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir. Med. 2011; 105 (3): 477–484. DOI: 10.1016/j.rmed.2010.08.011.Vozoris N.T., Stanbrook M.B. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir. Med. 2011; 105 (3): 477–484. DOI: 10.1016/j.rmed.2010.08.011.Малыхин Ф.Т. Показатели β-адренорецепции у пожилых больных с обострением хронического обструктивного бронхита. Вестник Российского Университета Дружбы Народов. Серия: Медицина. 2012; (1): 43–45. Доступно на: https://journals.rudn.ru/medicine/article/view/3300 [Дата обращения: 08.05.21].Malykhin F.T. [β-adrenoreception in the aged patients with recurrence of chronic obstructive bronchitis]. Vestnik Rossyskogo Universiteta Druzhby Narodov. Seriya: Meditsina. 2012; (1): 43–45. Available at: https://journals.rudn.ru/medicine/article/view/3300 [Accessed: May 08, 2021] (in Russian).Bateman E.D., Ferguson G.T., Barnes N. et al. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur. Respir. J. 2013; 42 (6): 1484–1494. DOI: 10.1183/09031936.00200212.Bateman E.D., Ferguson G.T., Barnes N. et al. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur. Respir. J. 2013; 42 (6): 1484–1494. DOI: 10.1183/09031936.00200212.Decramer M., Anzueto A., Kerwin E. et al. Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials. Lancet Respir. Med. 2014; 2 (6): 472–486. DOI: 10.1016/S2213-2600(14)70065-7.Decramer M., Anzueto A., Kerwin E. et al. Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials. Lancet Respir. Med. 2014; 2 (6): 472–486. DOI: 10.1016/S2213-2600(14)70065-7.Kruis A.L., Ställberg B., Jones R.C. et al. Chavannes N. H. Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One. 2014; 9 (3): e90145. DOI: 10.1371/journal.pone.0090145.Kruis A.L., Ställberg B., Jones R.C. et al. Chavannes N. H. Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One. 2014; 9 (3): e90145. DOI: 10.1371/journal.pone.0090145.Овчаренко С.И. Ингаляционные глюкокортикостероиды в терапии больных хронической обструктивной болезнью легких: быть или не быть?! Практическая пульмонология. 2016; (1): 16–22. Доступно на: http://www.atmosphere-ph.ru/modules/Magazines/articles/pulmo/PP_1_2016_16.pdf [Дата обращения: 08.05.21].Ovcharenko S.I. [Inhaled glucocorticosteroids in the treatment of patients with chronic obstructive pulmonary disease: to be or not to be?!]. Prakticheskaya pul’monologiya. 2016; (1): 16–22. Available at: http://www.atmosphere-ph.ru/modules/Magazines/articles/pulmo/PP_1_2016_16.pdf [Accessed: May 08, 2021] (in Russian).Goodman D.E., Israel E., Rosenberg M. et al. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am. J. Respir. Crit. Care Med. 1994; 150 (5, Pt 1): 1256–1261. DOI: 10.1164/ajrccm.150.5.7952549.Goodman D.E., Israel E., Rosenberg M. et al. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am. J. Respir. Crit. Care Med. 1994; 150 (5, Pt 1): 1256–1261. DOI: 10.1164/ajrccm.150.5.7952549.Robles P.G., Brooks D., Goldstein R. et al. Gender-associated differences in pulmonary rehabilitation outcomes in people with chronic obstructive pulmonary disease: a systematic review. J. Cardiopulm. Rehabil. Prev. 2014; 34 (2): 87–97. DOI: 10.1097/HCR.0000000000000018.Robles P.G., Brooks D., Goldstein R. et al. Gender-associated differences in pulmonary rehabilitation outcomes in people with chronic obstructive pulmonary disease: a systematic review. J. Cardiopulm. Rehabil. Prev. 2014; 34 (2): 87–97. DOI: 10.1097/HCR.0000000000000018.Dal Negro R.W., Bonadiman L., Turco P. Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidiscip Respir Med. 2015; 10 (1): 24. DOI: 10.1186/s40248-015-0023-2.Dal Negro R.W., Bonadiman L., Turco P. Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidiscip Respir Med. 2015; 10 (1): 24. DOI: 10.1186/s40248-015-0023-2.

The authors declare that there are no conflicts of interest present.